OBALON THERAPEUTICS INC 4
4 · OBALON THERAPEUTICS INC · Filed Nov 14, 2016
Insider Transaction Report
Form 4
Plovanic William J.
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2016-11-09+55,000→ 55,000 totalExercise: $8.74Exp: 2026-11-09→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the total shares on March 7, 2017, and then 2.0833% of the total shares monthly thereafter, with 100% of the total shares vested on March 7, 2020, subject to the reporting person's provision of service to the issuer on each vesting date.